A. Rodríguez

Plasma C3d Levels and Ischemic Heart Disease in Type II Diabetes

A. Fernandez-cruz, R. Patiño, J. Ibarra, 1993, Diabetes Care.

Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression.

A. Fernandez-cruz, R. Patiño, J. Ibarra, 2000, The American journal of cardiology.

Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis

A. Rodríguez, A. Marco, G. García-Blanch, 2005, Obesity surgery.

Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

A. Fernandez-cruz, R. Patiño, A. Rodríguez, 2002, Clinical Drug Investigation.

Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications.

A. Fernandez-cruz, R. Patiño, J. Ibarra, 1996, Clinical immunology and immunopathology.

Morbid Obesity and Gastric Bypass Surgery: Biochemical Profile

A. Marco, Y. Domínguez, G. García-Blanch, 2004, Obesity surgery.

Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone.

E. Caveda, R. Simó, A. Rodríguez, 2010, Current drug safety.

[Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery].

A. Marco, E. Aguirregoicoa, G. García-Blanch, 2007, Nutricion hospitalaria.